ADEBRELIMAB
UNII 1XBY50W1OX

Substance Identification & Data

This profile provides standardized clinical and technical data for Adebrelimab, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 1XBY50W1OX.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 2247114-85-6 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code
1XBY50W1OX
CAS Registry Number
2247114-85-6
RxNorm Concept ID
N/A

Detailed Substance Profile

Preferred Name
ADEBRELIMAB
Official standardized name for this substance within the FDA UNII nomenclature system.
NCI Thesaurus
C148535
National Cancer Institute reference terminology for clinical and research data.
INN ID
11300
Sequential identifier assigned via the WHO International Nonproprietary Name program.
Substance Type
protein
ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Adebrelimab. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

ADEBRELIMAB

Common Names & Synonyms

ADEBRELIMAB [INN]
ADEBRELIMAB [WHO-DD]
ANTI-PD-L1 MONOCLONAL ANTIBODY SHR-1316
IMMUNOGLOBULIN G4 (52-GLYCINE,57-PHENYLALANINE,227-PROLINE,233-ALANINE,234-ALANINE), ANTI-(HUMAN PROGRAMMED CELL DEATH PROTEIN 1) (HUMAN-MUS MUSCULUS MONOCLONAL SHR-1316 .GAMMA.4-CHAIN), DISULFIDE WITH HUMAN-MUS MUSCULUS MONOCLONAL SHR-1316 .KAPPA.-CHAIN (85-GLUTAMIC ACID), DIMER

Technical Codes

HTI-1088
SHR-1316

External Clinical & Regulatory Resources

CAS
Common Chemistry
NCATS
Inxight Drugs
NLM
DailyMed Products
NCATS
GSRS Full Record
NIH
NCI Thesaurus